This further confirms that K53 serves as a regulatory epitope for Apaf-1 binding and the activation of the caspase cascade and suggests an underlying mechanism for evasion of apoptosis in prostate cancer through K53 acetylation. Here, APAF1 is linked to prostate carcinoma.